Adial Pharmaceuticals' $64 Million Acquisition of Azora: What It Means for Biotech Investors
Adial Pharmaceuticals' acquisition of Azora Therapeutics signals strategic growth in the biotech sector, particularly for ulcerative colitis…
SpaceX IPO at $135: Nasdaq Debut, $85.7B Raised and SPCX Stock Since
SpaceX priced its record IPO at $135 a share on June 11, 2026, raising about $85.7 billion, and SPCX began trading on Nasdaq on June 12. The…
GSK's $10.6B Nuvalent Play: What Big Pharma's Consolidation Appetite Means for the Market
GlaxoSmithKline's $10.6 billion acquisition of Nuvalent signals continued M&A momentum in pharma, reshaping the competitive landscape.
Alphabet's $80 Billion Stock Sale: Analyzing Implications for Investors and the AI Market
Alphabet plans a massive $80 billion stock sale to fund AI developments, raising key investor questions about share prices and market positi…
Factorial Energy's SPAC Merger: What Investors Should Know
Factorial Energy's merger with Cartesian Growth Corporation III is set to shake up the EV battery sector. Here's what traders need to know.
ProLogium's Upcoming Nasdaq Listing: What Investors Should Know
ProLogium is set to make waves on Nasdaq through a SPAC merger. Dive into what this means for the battery sector.
New Energy Royalty Company Emerges: SoftVest and Blackbeard's Strategic Move
SoftVest and Blackbeard Holdings announce a significant business combination aimed at enhancing energy sector investments.